Adding oral verapamil once daily to a standard insulin regimen provides a safe and effective approach to promote and preserve the endogenous β-cell function, delay β-cell loss and disease progression, and reduce insulin requirements and hypoglycemic episodes in adults with recent-onset T1D. This evidence concerns the gene INS and type 1 diabetes mellitus.